Cibinqo Tablet, Film Coated
Product Images NDC 63539-336

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cibinqo (NDC 63539-336). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cibinqo 01)

Chemical structure of abrocitinib, the active ingredient in CIBINQO. The diagram shows the arrangement of atoms and bonds forming the molecule, including nitrogen, sulfur, oxygen, and carbon components.*

FDA Label Image

Logo (Cibinqo 02)

Packaging label showing a Pfizer logo with text indicating distribution by Pfizer Labs, Divisions of Pfizer Inc., located in New York, NY 10017. This label accompanies the prescription drug CIBINQO (abrocitinib) in film-coated tablet form, available in strengths of 50 mg, 100 mg, and 200 mg, distributed by U.S. Pharmaceuticals.*

FDA Label Image

Logo (Cibinqo 03)

Packaging label image showing distribution information for CIBINQO, indicating it is distributed by Pfizer Labs, a division of Pfizer Inc., located in New York, NY 10017. The Pfizer logo is also visible.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Label for CIBINQO (abrocitinib) tablets 50 mg, film-coated oral tablets. The label displays Pfizer as the manufacturer and includes storage instructions, dosage information noting each tablet contains 50 mg abrocitinib, and the package quantity of 14 tablets. It also includes a warning not to crush, split, or chew the tablets and states Rx only prescription status.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Label for CIBINQO (abrocitinib) tablets, 100 mg strength, oral film-coated tablets. The label includes dosage instructions, storage conditions, and warnings against crushing, splitting, or chewing the tablets. The package contains 14 tablets. Distributed by U.S. Pharmaceuticals and Pfizer, with an NDC of 63539-336-14. Made in Ireland.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

CIBINQO (abrocitinib) tablets 200 mg film-coated oral tablets in a 14-tablet package. Label states to store at 20°C to 25°C, keep in original package, and not to crush, split, or chew tablets. Distributed by U.S. Pharmaceuticals, Pfizer Inc., made in Ireland, with NDC 63539-436-14. Marked as professional sample, not for sale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.